🔎 Trials Near Me

Gara Jalqabaatti › Leukemia-Lymphoma Lymphoblastic T-Cell Duraa › New York › New York City

Qorannoo klinikaalii Leukemia-Lymphoma Lymphoblastic T-Cell Duraa New York City, NY keessatti

Qorannoo 6 Leukemia-Lymphoma Lymphoblastic T-Cell Duraa f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
6 Months · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06514794

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT04301076

A Registry for People With T-cell Lymphoma

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Weill Cornell Medical Center (Data Collection Only), New York
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umuriin hundi · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT05978141

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Icahn School of Medicine at Mount Sinai, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Elb-2026 · NCT05996185

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Bit-2026 · NCT06698003

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2025 · NCT06462365

Qorannoo Leukemia-Lymphoma Lymphoblastic T-Cell Duraa magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.